Related references
Note: Only part of the references are listed.FOX(M1) News-It Is Cancer
Marianna Halasi et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Prediction of outcome of early ER plus breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
E. K. A. Millar et al.
BRITISH JOURNAL OF CANCER (2011)
FoxM1: A Master Regulator of Tumor Metastasis
Pradip Raychaudhuri et al.
CANCER RESEARCH (2011)
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
S. Mook et al.
ANNALS OF ONCOLOGY (2010)
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
Marieke E. Straver et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
New Developments in Hormone Receptor-Positive Disease
Martine J. Piccart-Gebhart
ONCOLOGIST (2010)
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study
Stella Mook et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
A Conserved Phosphorylation Site within the Forkhead Domain of FoxM1B Is Required for Its Activation by Cyclin-CDK1
Yi-Ju Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
Nuran Bektas et al.
BMC CANCER (2008)
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)
[Anonymous]
LANCET ONCOLOGY (2007)
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
Marc Buyse et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Forkhead box m1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase
IC Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer
B Weigelt et al.
CANCER RESEARCH (2005)
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
R Jakesz et al.
LANCET (2005)
Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe
DR Wonsey et al.
CANCER RESEARCH (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
HY Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
A Howell et al.
LANCET (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data
C Pilarsky et al.
NEOPLASIA (2004)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Share Paper
